• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颅内椎基底动脉夹层动脉瘤血管内治疗后复发的发生率及危险因素。

Incidence and risk factors of recurrence after endovascular treatment of intracranial vertebrobasilar dissecting aneurysms.

机构信息

Yonsei University College of Medicine, Severance Hospital, 250 Seongsanno, 120-752, Seoul, Republic of Korea.

出版信息

Stroke. 2011 Sep;42(9):2425-30. doi: 10.1161/STROKEAHA.111.617381. Epub 2011 Jul 21.

DOI:10.1161/STROKEAHA.111.617381
PMID:21778439
Abstract

BACKGROUND AND PURPOSE

The incidence and risk factors for recurrence after endovascular treatment of intracranial vertebrobasilar dissecting aneurysms (VBDAs) have not been studied. We aimed to evaluate the incidence and risk factors for recurrence after endovascular treatment of VBDAs.

METHODS

A total of 111 patients (mean age, 45±10 years) underwent endovascular treatment for 119 VBDAs (ruptured/unruptured=73:46). Incidence and risk factors for recurrence were retrospectively evaluated.

RESULTS

Sixty-two VBDAs were treated by a reconstructive technique by using 1 to 3 overlapping stents with or without coiling, and 57 VBDAs were treated by a deconstructive technique by using proximal occlusion or internal trapping at the dissected segment of the parent artery. Follow-up angiography was available for 97 VBDAs (81.5%) in 89 patients at 3 days to 48 months (median, 13 months) after treatment. There were 13 recurrences: 6 had rebleeding but 7 had no rebleeding. All 6 hemorrhagic recurrences had initially presented with a ruptured form. Ten recurrences were confirmed by angiography, but 3 recurrences with rebleeding did not receive follow-up angiography. The rate of post-treatment recurrence did not differ between reconstructive and deconstructive treatments. Involvement of the posterior inferior cerebellar artery origin (odds ratio=8.026; 95% confidence interval, 1.561 to 41.259; P=0.013) was the only independent risk factor for recurrence.

CONCLUSIONS

There was a 13% recurrence after endovascular treatment of VBDAs. Posterior inferior cerebellar artery origin involvement was the only independent risk factor for recurrence after endovascular treatment of VBDAs.

摘要

背景与目的

颅内椎基底动脉夹层动脉瘤(VBDAs)血管内治疗后复发的发生率和危险因素尚未得到研究。本研究旨在评估血管内治疗 VBDAs 后复发的发生率和危险因素。

方法

共 111 例患者(平均年龄 45±10 岁)接受血管内治疗 119 个 VBDAs(破裂/未破裂=73:46)。回顾性评估复发的发生率和危险因素。

结果

62 个 VBDAs 采用重建技术,使用 1 至 3 个重叠支架,有或无线圈填塞,57 个 VBDAs 采用去结构技术,在母动脉夹层节段近端闭塞或内部夹闭。89 例患者中的 97 个 VBDAs(81.5%)可获得治疗后 3 天至 48 个月(中位数 13 个月)的随访血管造影。13 例复发:6 例再出血,7 例无再出血。所有 6 例出血性复发最初均表现为破裂形式。10 例复发经血管造影证实,但 3 例再出血复发未行随访血管造影。重建治疗与去结构治疗后复发率无差异。小脑后下动脉起源受累(优势比=8.026;95%置信区间,1.561 至 41.259;P=0.013)是复发的唯一独立危险因素。

结论

血管内治疗 VBDAs 后复发率为 13%。小脑后下动脉起源受累是血管内治疗 VBDAs 后复发的唯一独立危险因素。

相似文献

1
Incidence and risk factors of recurrence after endovascular treatment of intracranial vertebrobasilar dissecting aneurysms.颅内椎基底动脉夹层动脉瘤血管内治疗后复发的发生率及危险因素。
Stroke. 2011 Sep;42(9):2425-30. doi: 10.1161/STROKEAHA.111.617381. Epub 2011 Jul 21.
2
Aneurysm wall enhancement on magnetic resonance imaging as a risk factor for progression of unruptured vertebrobasilar dissecting aneurysms after reconstructive endovascular treatment.磁共振成像上的动脉瘤壁增强可作为重建性血管内治疗后未破裂椎基底动脉夹层动脉瘤进展的危险因素。
J Neurosurg. 2018 Mar;128(3):747-755. doi: 10.3171/2016.11.JNS162433. Epub 2017 Apr 7.
3
Clinical and angiographic follow-up of stent-only therapy for acute intracranial vertebrobasilar dissecting aneurysms.单纯支架治疗急性颅内椎基底动脉夹层动脉瘤的临床及血管造影随访
AJNR Am J Neuroradiol. 2009 Aug;30(7):1351-6. doi: 10.3174/ajnr.A1561. Epub 2009 Apr 2.
4
Long-term follow-up study of 35 cases after endovascular treatment for vertebrobasilar dissecting aneurysms.35例椎基底动脉夹层动脉瘤血管内治疗后的长期随访研究
Clin Neurol Neurosurg. 2015 Oct;137:121-31. doi: 10.1016/j.clineuro.2015.07.004. Epub 2015 Jul 7.
5
[Incidence and risk factors of recurrence after endovascular treatment of vertebrobasilar dissecting aneurysms].[椎基底动脉夹层动脉瘤血管内治疗后复发的发生率及危险因素]
Zhonghua Yi Xue Za Zhi. 2017 Jun 6;97(21):1655-1658. doi: 10.3760/cma.j.issn.0376-2491.2017.21.013.
6
Endovascular strategies for vertebrobasilar dissecting aneurysms.椎基底动脉夹层动脉瘤的血管内治疗策略
AJNR Am J Neuroradiol. 2009 Sep;30(8):1518-23. doi: 10.3174/ajnr.A1621. Epub 2009 May 27.
7
Endovascular treatment of isolated posterior inferior cerebellar artery dissecting aneurysms: parent artery occlusion or selective coiling?孤立性小脑后下动脉夹层动脉瘤的血管内治疗:载瘤动脉闭塞还是选择性弹簧圈栓塞?
Clin Neuroradiol. 2014 Sep;24(3):255-61. doi: 10.1007/s00062-013-0247-5. Epub 2013 Aug 4.
8
Ruptured intracranial dissecting aneurysms: management considerations with a focus on surgical and endovascular techniques to preserve arterial continuity.颅内夹层动脉瘤破裂:治疗考量,重点关注保留动脉连续性的外科手术和血管内技术。
Acta Neurochir (Wien). 2003 Dec;145(12):1073-83; discussion 1083-4. doi: 10.1007/s00701-003-0122-2. Epub 2003 Oct 13.
9
Magnetic Resonance Imaging Follow-Up of Large or Giant Vertebrobasilar Dissecting Aneurysms After Total Embolization on Angiography.血管造影完全栓塞后大型或巨大型椎基底动脉夹层动脉瘤的磁共振成像随访
World Neurosurg. 2016 Jul;91:218-27. doi: 10.1016/j.wneu.2016.04.024. Epub 2016 Apr 14.
10
Endovascular management of vertebrobasilar dissecting aneurysms.椎动脉夹层动脉瘤的血管内治疗
AJNR Am J Neuroradiol. 2003 Aug;24(7):1421-8.

引用本文的文献

1
Spontaneous Intracranial Vertebral Artery Dissection: A Rare Cause of Ischemic Stroke.自发性颅内椎动脉夹层:缺血性卒中的罕见病因。
J Cardiovasc Dev Dis. 2025 May 15;12(5):187. doi: 10.3390/jcdd12050187.
2
Intracranial vertebral artery dissection without hemorrhagic presentation.无出血表现的颅内椎动脉夹层
Neurol Sci. 2025 May 17. doi: 10.1007/s10072-025-08234-3.
3
Current status and prospects of endovascular treatment for intracranial vertebral artery aneurysms: A narrative review.颅内椎动脉动脉瘤血管内治疗的现状与展望:一项叙述性综述
Medicine (Baltimore). 2025 Apr 25;104(17):e42265. doi: 10.1097/MD.0000000000042265.
4
Risk factors for the persistence of unruptured intracranial vertebral artery dissecting aneurysms treated with flow diverters.血流导向装置治疗未破裂颅内椎动脉夹层动脉瘤持续存在的危险因素。
Sci Rep. 2025 Apr 21;15(1):13677. doi: 10.1038/s41598-025-98737-y.
5
Difficulty and prospects of endovascular treatment for spontaneous intracranial artery dissection.自发性颅内动脉夹层血管内治疗的难点与前景
Front Neurol. 2025 Mar 3;16:1560883. doi: 10.3389/fneur.2025.1560883. eCollection 2025.
6
Analysis of the efficacy and factors affecting the prognosis of intracranial dissecting aneurysm treated with multi-stent overlap technique.多支架重叠技术治疗颅内夹层动脉瘤的疗效及影响预后因素分析
BMC Neurol. 2024 Dec 31;24(1):495. doi: 10.1186/s12883-024-03991-8.
7
Microsurgical partial trapping for the treatment of unclippable vertebral artery aneurysms: Experience from 27 patients and review of literature.显微外科部分夹闭术治疗无法夹闭的椎动脉动脉瘤:27例患者的经验及文献复习
World Neurosurg X. 2023 Dec 5;21:100256. doi: 10.1016/j.wnsx.2023.100256. eCollection 2024 Jan.
8
Efficacy and predicting factors of multimodal treatment for ruptured intracranial vertebral artery dissecting aneurysms.破裂颅内椎动脉夹层动脉瘤的多模态治疗的疗效及预测因素。
Neurosurg Rev. 2023 Dec 1;46(1):321. doi: 10.1007/s10143-023-02226-7.
9
Endovascular Treatment of Intracranial Vertebral Artery Dissection.颅内椎动脉夹层的血管内治疗
J Neuroendovasc Ther. 2021;15(5):265-280. doi: 10.5797/jnet.ra.2020-0150. Epub 2021 Jan 11.
10
Target Embolization of Dilated Post-PICA Segment for Ruptured PICA-Involved Type Vertebral Artery Dissecting Aneurysm.针对累及小脑后下动脉(PICA)型椎动脉夹层动脉瘤破裂的扩张性PICA后段进行靶向栓塞
J Neuroendovasc Ther. 2021;15(9):565-573. doi: 10.5797/jnet.oa.2020-0157. Epub 2021 Jan 14.